Swedeheart研究
SpletiFR is a non-hyperaemic index for the assessment of coronary lesion severity, prior to iFR Swedeheart validation studies had shown similar ability to detect ischaemia compared with FFR. iFR Swedeheart aimed to test the hypothesis that iFR was non-inferior to FFR regarding a composite endpoint of all cause death, MI and unplanned revascularisation. SpletThe nationwide SWEDEHEART registry has monitored quality of care post myocardial infarction (MI) in Sweden since the 1990s. Follow-up data describing treatment and outcomes within CR has been ...
Swedeheart研究
Did you know?
Splet18. mar. 2024 · In Sweden, data on myocardial infarction and unplanned revascularization were obtained from the Swedish Web-Based System for Enhancement and Development … SpletStefan James is Professor of Cardiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center and a senior Interventional Cardiologist at Uppsala University Hospital Sweden. He is the president of the Swedish society of Cardiology and a Fellow of the ESC. Professor James co-chaired the previous and current 2024 ESC ...
SpletAims The aims of the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies (SWEDEHEART) are to support the improvement of care and evidence-based development of therapy of coronary artery disease (CAD). Interventions To provide users with online … SpletStudy design and objectives: The SWITCH SWEDEHEART trial is a prospective, multicenter, open-label, cross-sectional, stepped-wedge cluster-randomized clinical trial, in which administrative regions in Sweden will constitute the clusters. At the start of the study, all clusters will use ticagrelor as the P2Y12 inhibitor drug of choice for ACS.
Splet05. jan. 2024 · In a SWEDEHEART registry study of more than 9,000 MINOCA patients followed for 4 years, a propensity score model showed significantly reduced major adverse cardiovascular events (MACE) (composite of all-cause mortality, hospitalization for MI, ischemic stroke, and heart failure) in patients treated with statins or angiotensin … SpletThe SWEDEHEART study is the most recent study for the BioHeart project and was a collaboration between Sweden and Australia, looking at 62,048 patients over a period of 13 years. The SWEDEHEART study included an …
SpletAims: The aims of the Swedish Web-system for Enhancement and Development of Evidence-based care in Heart disease Evaluated According to Recommended Therapies …
Splet12. maj 2024 · The SWEDEHEART-CR registry includes patients with a first time or recurrent Type 1 MI (ICD codes I21 or I22) discharged alive between the age of 18–79 years and with a Swedish personal identification number. The age limit was increased from 74 to 79 years 1 January 2024, in concordance with longer life-expectancy and better survival after MI. ... tri swivel golf push cartSplet08. nov. 2024 · Karolina Szummer, MD, PhD, et al., looked at 205,693 NSTEMI cases in the SWEDEHEART Registry between 1994 and 2014. Results showed that the standardized one-year mortality ratio in NSTEMI compared to the control population decreased from 5.53 in 1995/1996 to 3.03 in 2013/2014. Further, there was an improvement in long-term survival … tri synergy septictank maintenanceSplet近日公布于esc年会的validate-swedeheart研究显示，心梗患者pci过程中使用比伐卢定或肝素后主要终点发生率并无显著差异。 2024-09-01 [esc2024]syntax ii：三支病变，放支架也许还是越少越好 . esc2024的pci会场最新研究中公布了syntax ii试验的研究结果：在三支病变 … tri sword fantastic frontier